Caplin Point Laboratories, 524742, CAPLIPOINT Share Price, Rating, Research, Analysis, Fundamental & Historical Data

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

15,928.25
29.70
2

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

15,337.39
0.14%
5.59

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

-
14.44
10.10

EBITDA CAGR (%)

10 Years
5 Years
3 Years

-
16.22
6.93

PAT CAGR (%)

10 Years
5 Years
3 Years

-
16.28
15.09

P:E (Median)

8 Years
5 Years
3 Years

19.89
20.20
22.13

P:BV (Average)

8 Years
5 Years
3 Years

6.11
4.38
4.55

EV:EBITDA (Average)

8 Years
5 Years
3 Years

15.16
14.57
15.86

Earnings Forecasts:

(Updated: 06-06-2025)

Description 2024 2025 2026 2027
Adj EPS 60.19 70.67 81.95 99.2
P/E Ratio 34.82 29.65 25.57 21.13
Revenue 1694 1937 2237 2633
EBITDA 551 647 750 914
Net Income 457 536 639 760
ROA 18.7 18.2 21.3 21.6
P/B Ratio 11.45 5.59 4.66 4.14
ROE 22.59 21.07 19.6 20.1
FCFF 216 292 434 485
FCFF Yield 1.39 1.89 2.81 3.14
Net Debt -789 -898 1796 1737
BVPS 183.05 375.01 450.08 506.58

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 25 Mar 24 Var% Dec 24 Dec 23 Var% Sep 24 Sep 23 Var% Jun 24 Jun 23 Var%
Net Sales 173.61 139.38 24.56% 185.23 132.83 39.45% 207.93 179.22 16.02% 185.64 173.66 6.90%
Expenses 98.57 81.70 20.65% 107.84 69.51 55.14% 109.77 89.77 22.28% 104.26 97.04 7.44%
EBITDA 75.04 57.68 30.10% 77.39 63.32 22.22% 98.16 89.45 9.74% 81.38 76.62 6.21%
EBIDTM 43.22% 41.38% 41.78% 47.67% 47.21% 49.91% 43.84% 44.12%
Other Income 41.25 36.18 14.01% 28.83 17.90 61.06% 43.01 24.49 75.62% 21.50 27.27 -21.16%
Interest 0.04 0.02 100.00% 0.04 0.03 33.33% 0.02 0.02 0.00% 0.02 0.03 -33.33%
Depreciation 6.09 6.93 -12.12% 6.01 6.76 -11.09% 6.49 6.72 -3.42% 6.18 6.67 -7.35%
PBT 110.16 86.91 26.75% 100.17 74.43 34.58% 134.66 107.20 25.62% 96.68 97.19 -0.52%
Tax 23.66 17.03 38.93% 25.46 18.98 34.14% 28.92 25.10 15.22% 24.14 20.92 15.39%
PAT 86.50 69.88 23.78% 74.71 55.45 34.73% 105.74 82.10 28.79% 72.54 76.27 -4.89%
PATM 49.82% 50.14% 40.33% 41.75% 50.85% 45.81% 39.08% 43.92%
EPS 11.38 9.19 23.83% 9.83 7.30 34.66% 13.91 10.80 28.80% 9.54 10.04 -4.98%

Description Mar 25 Mar 24 Var% Dec 24 Dec 23 Var% Sep 24 Sep 23 Var% Jun 24 Jun 23 Var%
Net Sales 502.45 453.22 10.86% 492.96 435.50 13.19% 483.10 410.06 17.81% 458.96 395.32 16.10%
Expenses 334.39 307.99 8.57% 330.67 293.22 12.77% 318.34 272.66 16.75% 307.15 268.79 14.27%
EBITDA 168.06 145.23 15.72% 162.29 142.28 14.06% 164.76 137.40 19.91% 151.81 126.53 19.98%
EBIDTM 33.45% 32.04% 32.92% 32.67% 34.10% 33.51% 33.08% 32.01%
Other Income 25.74 17.29 48.87% 31.36 17.18 82.54% 20.77 20.43 1.66% 18.56 12.04 54.15%
Interest 0.17 0.15 13.33% 0.18 0.17 5.88% 0.21 0.18 16.67% 0.05 0.28 -82.14%
Depreciation 17.04 16.40 3.90% 16.20 13.90 16.55% 16.76 11.76 42.52% 15.96 11.38 40.25%
PBT 176.59 145.97 20.98% 177.27 145.39 21.93% 168.56 145.89 15.54% 154.36 126.91 21.63%
Tax 31.39 24.80 26.57% 37.19 25.59 45.33% 37.65 29.86 26.09% 29.46 22.76 29.44%
PAT 145.20 121.17 19.83% 140.08 119.80 16.93% 130.91 116.03 12.82% 124.90 104.15 19.92%
PATM 28.90% 26.74% 28.42% 27.51% 27.10% 28.30% 27.21% 26.35%
EPS 18.76 16.01 17.18% 18.28 15.43 18.47% 17.21 15.12 13.82% 16.31 13.62 19.75%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Description TTM Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Jun 15
Net Sales 752.41 625.09 528.61 528.06 482.68 527.83 536.91 426.57 341.55 231.29 240.23 Net Sales Growth 20.37% 18.25% 0.10% 9.40% -8.55% -1.69% 25.87% 24.89% 47.67% -3.72% Cost Of Goods Sold 238.17 205.22 198.06 204.65 194.83 238.18 237.03 180.11 161.94 116.73 128.25 Gross Profit 514.24 419.87 330.55 323.41 287.85 289.65 299.87 246.46 179.61 114.56 111.98 GP Margin 68.35% 67.17% 62.53% 61.24% 59.64% 54.88% 55.85% 57.78% 52.59% 49.53% 46.61% Total Expenditure 420.44 338.01 309.23 308.58 273.14 320.83 348.31 284.33 247.72 168.78 183.03 Power & Fuel Cost - 15.43 9.89 9.54 6.36 7.19 12.29 10.96 9.85 7.55 8.39 % Of Sales - 2.47% 1.87% 1.81% 1.32% 1.36% 2.29% 2.57% 2.88% 3.26% 3.49% Employee Cost - 37.18 35.81 29.91 26.03 24.39 40.49 37.29 29.48 17.58 17.84 % Of Sales - 5.95% 6.77% 5.66% 5.39% 4.62% 7.54% 8.74% 8.63% 7.60% 7.43% Manufacturing Exp. - 54.17 42.18 34.68 27.15 33.34 38.72 37.02 28.34 13.84 15.59 % Of Sales - 8.67% 7.98% 6.57% 5.62% 6.32% 7.21% 8.68% 8.30% 5.98% 6.49% General & Admin Exp. - 18.24 13.52 12.55 6.50 8.55 14.96 12.18 12.63 7.60 7.43 % Of Sales - 2.92% 2.56% 2.38% 1.35% 1.62% 2.79% 2.86% 3.70% 3.29% 3.09% Selling & Distn. Exp. - 1.88 3.91 12.23 2.78 5.89 2.64 4.74 5.37 2.11 2.62 % Of Sales - 0.30% 0.74% 2.32% 0.58% 1.12% 0.49% 1.11% 1.57% 0.91% 1.09% Miscellaneous Exp. - 5.89 5.86 5.02 9.49 3.29 2.17 2.03 0.11 3.38 2.62 % Of Sales - 0.94% 1.11% 0.95% 1.97% 0.62% 0.40% 0.48% 0.03% 1.46% 1.21% EBITDA 331.97 287.08 219.38 219.48 209.54 207.00 188.60 142.24 93.83 62.51 57.20 EBITDA Margin 44.12% 45.93% 41.50% 41.56% 43.41% 39.22% 35.13% 33.35% 27.47% 27.03% 23.81% Other Income 134.59 105.84 99.54 56.69 23.01 65.97 35.40 23.31 12.51 3.47 2.74 Interest 0.12 0.10 0.12 0.09 0.17 0.19 0.50 0.52 0.50 0.31 0.87 Depreciation 24.77 27.08 25.65 25.77 22.44 19.65 20.84 18.99 13.26 7.30 8.28 PBT 441.67 365.74 293.15 250.31 209.94 253.12 202.65 146.05 92.58 58.38 50.80 Tax 102.18 82.03 58.89 62.44 53.71 55.49 54.49 43.74 22.26 13.05 9.86 Tax Rate 23.13% 22.43% 20.09% 24.95% 25.58% 21.92% 26.89% 29.95% 24.04% 22.35% 19.41% PAT 339.49 283.71 234.26 187.87 156.23 197.64 148.17 102.31 70.32 45.33 40.94 PAT before Minority Interest 339.49 283.71 234.26 187.87 156.23 197.64 148.17 102.31 70.32 45.33 40.94 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 45.12% 45.39% 44.32% 35.58% 32.37% 37.44% 27.60% 23.98% 20.59% 19.60% 17.04% PAT Growth 19.67% 21.11% 24.69% 20.25% -20.95% 33.39% 44.82% 45.49% 55.13% 10.72% EPS 44.67 37.33 30.82 24.72 20.56 26.01 19.50 13.46 9.25 5.96 5.39

Description TTM Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Jun 15
Net Sales 1,937.47 1,694.10 1,466.73 1,269.41 1,061.29 863.20 648.69 539.84 401.65 238.72 251.77 Net Sales Growth 14.37% 15.50% 15.54% 19.61% 22.95% 33.07% 20.16% 34.41% 68.25% -5.18% Cost Of Goods Sold 770.85 724.18 663.21 557.51 471.74 413.16 288.78 238.18 184.93 121.16 135.62 Gross Profit 1,166.62 969.92 803.52 711.90 589.55 450.04 359.91 301.66 216.72 117.56 116.15 GP Margin 60.21% 57.25% 54.78% 56.08% 55.55% 52.14% 55.48% 55.88% 53.96% 49.25% 46.13% Total Expenditure 1,290.55 1,142.65 1,026.21 874.88 737.04 603.13 416.84 344.52 276.84 174.51 192.06 Power & Fuel Cost - 33.57 25.53 21.40 16.36 14.81 13.76 10.98 9.91 7.56 8.61 % Of Sales - 1.98% 1.74% 1.69% 1.54% 1.72% 2.12% 2.03% 2.47% 3.17% 3.42% Employee Cost - 142.66 136.12 114.74 101.97 67.15 45.58 37.61 29.71 17.92 18.24 % Of Sales - 8.42% 9.28% 9.04% 9.61% 7.78% 7.03% 6.97% 7.40% 7.51% 7.24% Manufacturing Exp. - 117.73 90.99 82.01 69.85 68.23 43.49 37.11 28.56 14.33 16.04 % Of Sales - 6.95% 6.20% 6.46% 6.58% 7.90% 6.70% 6.87% 7.11% 6.00% 6.37% General & Admin Exp. - 89.41 85.38 66.68 38.53 25.50 20.82 12.27 13.78 8.15 7.97 % Of Sales - 5.28% 5.82% 5.25% 3.63% 2.95% 3.21% 2.27% 3.43% 3.41% 3.17% Selling & Distn. Exp. - 28.44 18.78 27.52 18.03 9.95 2.08 5.92 9.41 2.29 2.85 % Of Sales - 1.68% 1.28% 2.17% 1.70% 1.15% 0.32% 1.10% 2.34% 0.96% 1.13% Miscellaneous Exp. - 6.66 6.20 5.02 20.56 4.33 2.33 2.45 0.55 3.10 2.85 % Of Sales - 0.39% 0.42% 0.40% 1.94% 0.50% 0.36% 0.45% 0.14% 1.30% 1.08% EBITDA 646.92 551.45 440.52 394.53 324.25 260.07 231.85 195.32 124.81 64.21 59.71 EBITDA Margin 33.39% 32.55% 30.03% 31.08% 30.55% 30.13% 35.74% 36.18% 31.07% 26.90% 23.72% Other Income 96.43 66.94 56.52 38.89 27.93 41.33 19.03 12.67 9.96 3.66 3.03 Interest 0.61 0.78 0.78 0.70 1.59 0.32 0.58 0.61 0.52 0.34 0.97 Depreciation 65.96 53.44 44.99 46.90 36.97 31.62 23.43 19.00 13.30 7.48 8.38 PBT 676.78 564.17 451.27 385.82 313.62 269.46 226.88 188.38 120.95 60.05 53.39 Tax 135.69 103.01 74.36 77.37 62.19 54.38 50.32 43.74 25.44 14.28 12.26 Tax Rate 20.05% 18.26% 16.48% 20.05% 19.83% 20.18% 22.18% 23.22% 21.03% 23.78% 22.96% PAT 541.09 457.09 376.26 299.84 242.27 215.00 176.56 144.78 95.61 45.77 41.04 PAT before Minority Interest 536.31 461.42 376.99 308.45 251.43 215.08 176.56 144.63 95.50 45.77 41.13 Minority Interest -4.78 -4.33 -0.73 -8.61 -9.16 -0.08 0.00 0.15 0.11 0.00 -0.09 PAT Margin 27.93% 26.98% 25.65% 23.62% 22.83% 24.91% 27.22% 26.82% 23.80% 19.17% 16.30% PAT Growth 17.33% 21.48% 25.49% 23.76% 12.68% 21.77% 21.95% 51.43% 108.89% 11.53% EPS 71.20 60.14 49.51 39.45 31.88 28.29 23.23 19.05 12.58 6.02 5.40

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Jun 15
Shareholder's Funds 1,390.15 1,139.91 930.65 758.67 599.91 432.04 295.60 200.12 128.14 93.63 Share Capital 15.19 15.18 15.16 15.13 15.13 15.13 15.12 15.12 15.11 15.11 Total Reserves 1,360.74 1,109.36 900.04 728.75 575.34 410.06 277.19 184.91 111.40 78.52 Non-Current Liabilities 12.86 16.42 24.63 24.99 27.16 24.77 27.86 19.90 13.69 10.39 Secured Loans 0.00 0.00 0.00 0.00 0.02 0.29 0.32 0.48 0.73 0.88 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.40 1.63 0.82 Current Liabilities 119.30 146.85 98.88 77.33 64.26 82.51 87.34 97.05 120.77 119.18 Trade Payables 78.62 70.63 65.02 70.11 51.41 59.50 72.89 66.01 51.47 38.04 Other Current Liabilities 36.26 65.26 32.66 6.06 11.97 21.76 13.86 29.37 60.37 71.36 Short Term Borrowings 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.05 Short Term Provisions 4.42 10.96 1.20 1.16 0.87 1.25 0.58 1.67 8.92 9.73 Total Liabilities 1,522.31 1,303.18 1,054.16 860.99 691.33 539.32 410.80 317.07 262.60 223.20 Net Block 165.79 156.85 162.46 182.68 166.93 137.77 169.32 151.75 142.75 111.47 Gross Block 318.45 285.13 268.64 266.22 228.35 179.85 231.63 195.07 178.70 140.64 Accumulated Depreciation 152.66 128.28 106.18 83.54 61.43 42.08 62.31 43.32 35.94 29.17 Non Current Assets 819.21 641.48 448.49 348.35 310.59 251.37 197.59 180.34 147.78 146.11 Capital Work in Progress 27.75 42.68 2.60 1.36 3.77 8.62 15.29 3.42 0.23 30.63 Non Current Investment 346.17 274.97 212.73 138.64 135.54 98.62 1.87 14.58 1.43 1.44 Long Term Loans & Adv. 272.07 164.70 70.70 5.67 4.36 6.36 11.11 10.59 3.37 2.57 Other Non Current Assets 7.43 2.28 0.00 20.00 0.00 0.00 0.00 0.00 0.00 0.00 Current Assets 703.10 661.70 605.67 512.64 380.74 287.95 213.21 136.73 114.82 77.10 Current Investments 237.98 210.18 51.97 10.54 60.23 69.62 46.34 4.20 0.00 0.00 Inventories 86.25 51.53 42.81 24.87 22.37 23.52 28.46 22.29 17.90 12.66 Sundry Debtors 128.67 88.24 53.73 98.46 218.98 125.39 86.35 3.21 6.80 0.02 Cash & Bank 215.78 271.38 316.08 345.49 58.27 44.85 28.28 76.66 64.77 40.32 Other Current Assets 34.42 2.17 11.97 18.31 20.89 24.56 23.78 30.37 25.35 24.10 Short Term Loans & Adv. 32.15 38.20 129.11 14.97 10.57 15.95 17.00 23.05 14.93 18.59 Net Current Assets 583.80 514.85 506.79 435.31 316.48 205.44 125.87 39.67 -5.95 -42.08 Total Assets 1,522.31 1,303.18 1,054.16 860.99 691.33 539.32 410.80 317.07 262.60 223.21

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Jun 15
Shareholder's Funds 2,315.71 1,880.48 1,483.93 1,185.83 947.91 632.91 363.83 224.76 128.14 93.19 Share Capital 89.77 89.76 89.74 89.71 89.71 51.05 15.12 15.12 15.11 15.11 Total Reserves 2,211.72 1,775.35 1,378.74 1,081.33 848.76 575.01 345.42 209.56 111.40 78.08 Non-Current Liabilities 7.46 2.13 12.55 17.39 24.86 23.42 27.86 19.90 13.69 10.39 Secured Loans 0.00 0.00 0.00 0.00 0.02 0.29 0.32 0.48 0.73 0.88 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 8.61 7.78 8.48 5.69 5.23 0.13 0.00 0.40 1.63 0.82 Current Liabilities 331.28 268.00 207.68 142.85 144.32 86.11 108.67 113.36 125.04 124.97 Trade Payables 209.41 152.56 155.94 88.50 64.14 60.47 94.23 78.60 55.71 41.56 Other Current Liabilities 110.50 99.94 48.68 51.87 79.28 24.20 13.86 33.09 60.39 72.11 Short Term Borrowings 0.28 3.41 0.50 0.00 0.00 0.00 0.00 0.00 0.00 0.05 Short Term Provisions 11.09 12.09 2.56 2.48 0.91 1.44 0.58 1.67 8.94 11.25 Total Liabilities 2,685.57 2,177.40 1,730.11 1,363.61 1,125.75 742.52 500.45 358.38 267.14 228.82 Net Block 452.66 279.81 286.57 305.34 272.50 226.84 169.48 151.83 144.23 113.13 Gross Block 702.31 480.32 445.74 422.58 354.79 271.51 231.79 195.15 180.76 142.71 Accumulated Depreciation 249.65 200.51 159.17 117.24 82.29 44.67 62.31 43.31 36.53 29.58 Non Current Assets 792.65 625.21 432.29 349.04 303.23 248.83 196.34 179.16 148.61 146.95 Capital Work in Progress 116.62 220.71 17.73 13.88 20.12 9.70 15.29 3.42 0.23 30.63 Non Current Investment 137.63 70.52 37.01 0.66 0.56 0.33 0.33 13.24 0.44 0.45 Long Term Loans & Adv. 78.31 51.51 89.90 7.92 10.05 11.95 11.23 10.67 3.71 2.75 Other Non Current Assets 7.43 2.66 1.08 21.24 0.00 0.00 0.00 0.00 0.00 0.00 Current Assets 1,892.92 1,552.19 1,297.82 1,014.57 822.53 493.69 304.11 179.22 118.53 81.87 Current Investments 237.98 210.18 51.97 10.54 60.23 69.62 46.34 4.20 0.00 0.00 Inventories 363.04 288.22 227.31 179.01 238.23 37.45 28.46 22.29 18.81 13.66 Sundry Debtors 542.72 394.06 317.05 279.36 228.96 159.81 125.88 33.02 7.95 5.66 Cash & Bank 552.74 493.48 462.99 438.33 223.43 152.99 79.28 93.07 68.10 45.37 Other Current Assets 196.44 22.82 13.61 20.25 71.68 73.83 24.16 26.63 23.67 17.18 Short Term Loans & Adv. 146.01 143.43 224.89 87.08 56.81 64.61 17.28 19.31 12.58 11.08 Net Current Assets 1,561.64 1,284.19 1,090.14 871.72 678.21 407.58 195.44 65.86 -6.51 -43.10 Total Assets 2,685.57 2,177.40 1,730.11 1,363.61 1,125.76 742.52 500.45 358.38 267.14 228.82

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Jun 15
Cash From Operating Activity 111.01 157.10 230.97 294.64 87.01 107.34 22.61 55.49 44.37 49.53 PBT 365.74 293.15 250.31 209.94 253.12 202.65 146.05 92.58 58.38 50.80 Adjustment -68.57 -59.57 -19.43 7.75 -32.58 -0.29 3.44 8.06 3.89 6.32 Changes in Working Capital -99.07 -11.45 62.07 131.85 -83.19 -54.17 -92.59 -24.76 -7.20 1.91 Cash after chg. in Working capital 198.10 222.13 292.95 349.54 137.36 148.19 56.90 75.88 55.07 59.03 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -87.09 -65.03 -61.98 -54.90 -50.35 -40.84 -34.29 -20.39 -10.69 -9.50 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -118.94 -86.67 -275.93 -3.71 -41.06 -76.51 -59.71 -37.07 -5.98 -23.76 Net Fixed Assets -18.39 -56.57 -3.66 -35.46 -43.65 58.45 -48.43 -19.56 -7.66 -25.72 Net Investments -99.00 -220.45 -115.52 46.59 -27.53 -120.03 -29.43 -17.35 0.01 -0.90 Others -1.55 190.35 -156.75 -14.84 30.12 -14.93 18.15 -0.16 1.67 2.86 Cash from Financing Activity -34.26 -30.42 -22.76 -3.47 -32.92 -15.21 -11.60 -6.74 -13.95 -8.62 Net Cash Inflow / Outflow -42.19 40.01 -67.72 287.46 13.03 15.62 -48.70 11.67 24.45 17.15 Opening Cash & Equivalents 122.02 81.01 148.82 55.61 42.52 26.18 74.89 63.22 40.32 23.17 Closing Cash & Equivalent 80.64 122.02 81.01 342.88 55.61 42.52 26.18 74.89 64.77 40.32

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Jun 15
Cash From Operating Activity 318.39 271.37 336.73 268.61 44.68 83.42 66.49 67.61 42.40 49.88 PBT 564.43 451.35 385.82 313.62 269.46 226.88 188.38 120.95 60.05 53.39 Adjustment 2.40 11.77 30.44 23.09 7.09 19.12 14.84 8.61 3.87 6.21 Changes in Working Capital -139.44 -103.75 1.96 -1.96 -177.11 -120.06 -100.38 -38.39 -5.13 1.96 Cash after chg. in Working capital 427.39 359.37 418.22 334.75 99.44 125.94 102.84 91.16 58.78 61.56 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -109.00 -88.00 -81.49 -66.14 -54.76 -42.51 -36.35 -23.55 -16.38 -11.67 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -320.04 -217.58 -376.77 -29.44 -54.50 -100.46 -69.02 -36.11 -5.72 -22.66 Net Fixed Assets -18.39 -56.57 -3.66 -35.46 -43.65 58.45 -48.43 -19.56 -7.66 -25.72 Net Investments -99.00 -220.45 -115.52 46.59 -27.53 -120.03 -29.43 -17.35 0.01 -0.90 Others -202.65 59.44 -257.59 -40.57 16.68 -38.88 8.84 0.80 1.93 3.96 Cash from Financing Activity -38.07 -28.17 -40.68 -23.98 79.77 89.79 -11.60 -6.74 -13.95 -8.67 Net Cash Inflow / Outflow -39.72 25.62 -80.72 215.19 69.94 72.76 -14.13 24.76 22.73 18.55 Opening Cash & Equivalents 177.56 150.76 231.57 220.77 150.65 77.17 91.31 66.55 45.37 26.82 Closing Cash & Equivalent 138.55 170.92 150.76 435.72 220.77 150.65 77.17 91.31 68.10 45.37

Financial Ratios

Consolidated /

Standalone

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Jun 15
Book Value (Rs.) 181.16 148.16 120.74 98.33 78.06 56.22 38.66 26.47 16.25 11.90 ROA 20.08% 19.87% 19.62% 20.13% 32.12% 31.19% 28.11% 24.26% 18.66% 20.60% ROE 22.69% 22.97% 22.65% 23.42% 38.92% 41.30% 41.56% 43.57% 42.62% 55.15% ROCE 28.92% 28.33% 29.64% 30.92% 49.05% 55.76% 58.99% 56.89% 53.75% 67.20% Fixed Asset Turnover 2.07 1.91 1.97 1.95 2.59 2.61 2.00 1.83 1.45 1.84 Receivable days 63.33 49.01 52.60 120.02 119.07 71.97 38.32 5.35 5.38 0.02 Inventory Days 40.23 32.57 23.39 17.86 15.87 17.67 21.71 21.48 24.11 15.55 Payable days 132.73 124.99 120.50 113.83 61.02 67.67 86.81 85.61 98.57 65.47 Cash Conversion Cycle -29.17 -43.41 -44.52 24.05 73.91 21.97 -26.78 -58.79 -69.08 -49.90 Total Debt/Equity 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.02 0.02 Interest Cover 3658.40 2443.92 2782.22 1235.94 1369.24 404.61 281.22 185.02 190.79 59.55

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Jun 15
Book Value (Rs.) 293.21 235.91 183.89 144.94 114.21 78.03 47.69 29.73 16.25 11.84 ROA 18.98% 19.30% 19.94% 20.20% 23.02% 28.41% 33.68% 30.54% 18.46% 20.12% ROE 22.97% 23.68% 24.77% 25.65% 29.58% 37.14% 49.43% 54.97% 43.13% 55.78% ROCE 26.92% 26.85% 28.77% 28.82% 33.35% 45.59% 64.08% 69.03% 55.41% 71.11% Fixed Asset Turnover 2.87 3.17 2.92 2.73 2.76 2.58 2.53 2.14 1.48 1.89 Receivable days 100.92 88.48 85.74 87.41 82.19 80.37 53.72 18.62 10.40 4.17 Inventory Days 70.16 64.15 58.42 71.75 58.28 18.54 17.16 18.68 24.83 17.00 Payable days 91.22 84.89 80.02 59.05 28.33 65.76 89.68 88.17 103.48 69.75 Cash Conversion Cycle 79.85 67.73 64.14 100.11 112.15 33.15 -18.80 -50.88 -68.24 -48.58 Total Debt/Equity 0.00 0.00 0.00 0.01 0.04 0.00 0.00 0.00 0.02 0.02 Interest Cover 724.63 579.65 552.17 198.25 843.86 391.22 309.72 235.08 179.35 56.11

Top Investors:

investor education and protection fund authority ministry of corporate affairs

uti small cap fund

llp

Annual Reports:

News Update:

Caplin Point Laboratories’ arm executes SPA to acquire entire stake in Triwin Pharma
4th Jun 2025, 15:41 PM

Triwin Pharma’s object is to operate in Mexico in the Pharmaceutical Marketing and Distribution business
Read More
Caplin Point’s arm gets USFDA’s final nod for Haloperidol Decanoate Injection
14th May 2025, 14:28 PM

Haloperidol Decanoate Injection had US sales of around $16.4 million for the 12- month period ending March 2025
Read More
Caplin Point Laboratories’ arm gets USFDA’s approval for Phytonadione Injectable Emulsion
23rd Apr 2025, 15:18 PM

Phytonadione Injectable Emulsion had US sales of around $18.5 million for the 12-month period ending February 2025
Read More
Caplin Point Laboratories’ arm acquires Neoethicals Chile SpA
2nd Apr 2025, 17:05 PM

The Caplin Point Far East’s board had approved the investment in Neoethicals Chile SpA through the purchase of all its shares
Read More

Caplin Point Laboratories Ltd.

Pharmaceuticals & Drugs - Global

BSE: 524742 | NSE: CAPLIPOINT

Stock Summary

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Earnings Forecasts:

Quarterly Results

Consolidated Figures in Rs. Crores /

Annual Results

Consolidated Figures in Rs. Crores /

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Cash Flow

Consolidated Figures in Rs. Crores /

Financial Ratios

Consolidated /

Top Investors:

Annual Reports:

News Update:

Caplin Point Laboratories Ltd.

Pharmaceuticals & Drugs - Global

BSE: 524742 | NSE: CAPLIPOINT

Stock Summary

Shareholding Pattern

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Earnings Forecasts:

Quarterly Results

Consolidated Figures in Rs. Crores /

Annual Results

Consolidated Figures in Rs. Crores /

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Cash Flow

Consolidated Figures in Rs. Crores /

Financial Ratios

Consolidated /

Top Investors:

Annual Reports:

News Update: